Ashley Wagner and Cullen Jones to Support the Launch of Mikra
TORONTO, April 13, 2022 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced its wholly owned U.S. subsidiary, Mikra Cellular Sciences Inc. (“Mikra”), has engaged Olympic medalists Ashley Wagner and Cullen Jones as Brand Ambassadors.
Ashley Wagner is a bronze medalist in figure skating at the 2014 Sochi Winter Olympics and a silver medalist at the 2016 World Championships. Since Michelle Kwan in 1999, Wagner was the first U.S. senior ladies figure skater to win three national championships (2012, 2013 and 2015).
Cullen Jones is a gold medalist in swimming at the 2008 Olympic Games in the 4x100m freestyle, and won two silvers (4x100m freestyle relay and 50m freestyle) and a gold in the 4x100m medley relay at the 2012 Olympic Games. He also won two gold medals and one silver medal at the swimming world championships.
“To complement our development deal with baseball hero Jose Bautista, Mikra continues to assemble a roster of athletic role models and amazing humans to support the launch of Mikra and push our mission of increasing the world’s healthspan forward,” said Faraaz Jamal, COO of Lifeist and CEO of Mikra. “Both Ashley and Cullen are inspirations and trailblazers, and we are privileged that they are part of the Mikra family. Together, we plan to help humans around the world enjoy better cellular health.”
“Mikra is a centerpiece of Lifeist's wellness mission to improve human health, and I couldn't be more encouraged with the path that it is on,” said Meni Morim, CEO of Lifeist. “After recently introducing its first breakthrough product, CELLF, Faraaz and team are continuing to build the ecosystem around Mikra with these world class athletes. We are just getting started as we go after the massive nutraceuticals market which is worth over $100 billion dollars in the U.S. alone.”
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards; CannMart Labs, a BHO extraction facility for the production of high margin cannabis 2.0 products; the CannMart.com marketplace, which provides U.S. customers with access to hemp-derived CBD and smoking accessories; Australian Vapes, the country’s largest online retailer of vaporizers and accessories; Findify, a leading AI-powered search and discovery platform; and Mikra, a biosciences and consumer wellness company seeking to develop innovative therapies for cellular health.
Information on Lifeist and its businesses can be accessed through the links below:
www.lifeist.com
www.cannmart.com
www.australianvaporizers.com.au
www.wearemikra.com
Contacts
Lifeist Wellness Inc.
Meni Morim, CEO
Matt Chesler, CFA, Investor Relations
Ph: 647-362-0390
Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen.
The forward-looking information contained herein, including, without limitation, statements related to Mikra’s ongoing and future development plans in the nutraceuticals market are made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made, including, without limitation, brand ambassadors will be an integral part of Mikra’s successful development, its expectation that the nutraceutical market will develop as currently anticipated, the nutraceutical market will continue to be a multi-billion dollar high-margin market, the introduction of new products and brands will generate additional revenue, expectations that CELLF and other cellular health products and accessories to be developed by the Company will gain market acceptance along with the expansion of the market for nutraceutical products, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: the inability of the Company to develop Mikra’s business as anticipated, unanticipated changes to current regulations that would adversely impact Mikra’s business, unforeseen developments that would delay Mikra’s ability to sell CELLF or any other nutraceutical products, the risk that the expected demand for nutraceutical products in general and those of Mikra in particular does not develop as anticipated and risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Source: Lifeist Wellness Inc.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/63fc97a9-aac1-41d1-a025-107f9936031d
https://www.globenewswire.com/NewsRoom/AttachmentNg/ecd17e83-9997-4c9b-bf0b-4f501dfe5983
